The mRNA COVID-19 vaccines developed by Pfizer and Moderna continue to save lives. But a new paper published in the journal Vaccines provides evidence that the two vaccines are not equivalent when it comes to protecting older adults against death.
Moderna beats Pfizer among two-dose COVID vaccine recipients aged 60 and over, study shows
